Corporate News     16-Aug-22
Board of Shankar Lal Rampal Dye-Chem recommends Final Dividend
Of Rs.0.05 per share
Shankar Lal Rampal Dye-Chem announced that the Board of Directors of the Company at its meeting held on 13 August 2022, has recommended a Final dividend of Rs.0.05 per share (i.e.0.5%), subject to the approval of the shareholders.
Previous News
  Shankar Lal Rampal Dye-Chem to convene board meeting
 ( Corporate News - 20-Jul-19   17:25 )
  Board of Shankar Lal Rampal Dye-Chem recommends final dividend
 ( Corporate News - 08-Aug-20   09:21 )
  Board of Shankar Lal Rampal Dye-Chem approves bonus issue
 ( Corporate News - 21-Sep-20   18:54 )
  Board of Shankar Lal Rampal Dye-Chem recommends final dividend
 ( Corporate News - 17-Aug-23   11:49 )
  Shankar Lal Rampal Dye-Chem announces board meeting date
 ( Corporate News - 14-Dec-21   12:15 )
  Shankar Lal Rampal Dye-Chem schedules AGM
 ( Corporate News - 17-Aug-23   11:47 )
  Board of Shankar Lal Rampal Dye-Chem to consider bonus issue
 ( Corporate News - 21-May-22   13:24 )
  Shankar Lal Rampal Dye-Chem to table results
 ( Corporate News - 27-Jan-20   13:58 )
  Shankar Lal Rampal Dye-Chem standalone net profit rises 315.96% in the December 2021 quarter
 ( Results - Announcements 15-Feb-22   08:50 )
  Shankar Lal Rampal Dye-Chem standalone net profit rises 36.02% in the September 2024 quarter
 ( Results - Announcements 14-Nov-24   18:26 )
  Shankar Lal Rampal Dye-Chem to hold AGM
 ( Corporate News - 27-Jul-21   10:25 )
Other Stories
  Board of HCL Technologies recommends Interim Dividend
  14-Jul-25   17:52
  Objectone Information Systems to conduct board meeting
  14-Jul-25   17:50
  JTEKT India AGM scheduled
  14-Jul-25   17:50
  Setco Automotive to discuss results
  14-Jul-25   17:50
  Saurashtra Cement to hold board meeting
  14-Jul-25   17:49
  John Cockerill India to table results
  14-Jul-25   17:49
  ATV Projects India to conduct board meeting
  14-Jul-25   17:49
  Shilchar Technologies schedules AGM
  14-Jul-25   17:49
  Sun Pharma settles litigation related to LEQSELVI™ with Incyte
  14-Jul-25   16:53
  Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
  14-Jul-25   16:48
Back Top